BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 12065564)

  • 21. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer?
    Merrick GS; Butler WM; Lief JH; Dorsey AT
    Tech Urol; 2001 Mar; 7(1):12-9. PubMed ID: 11272667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy.
    Leonardo C; Simone G; Papalia R; Franco G; Guaglianone S; Gallucci M
    Int J Urol; 2009 Jun; 16(6):584-6. PubMed ID: 19453762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician visits prior to treatment for clinically localized prostate cancer.
    Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
    Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
    Kim WY; Whang YE; Pruthi RS; Baggstrom MQ; Rathmell WK; Rosenman JG; Wallen EM; Goyal LK; Grigson G; Watkins C; Godley PA
    Urol Oncol; 2011; 29(6):608-13. PubMed ID: 20022268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The burden of out-of-pocket and indirect costs of prostate cancer.
    Jayadevappa R; Schwartz JS; Chhatre S; Gallo JJ; Wein AJ; Malkowicz SB
    Prostate; 2010 Aug; 70(11):1255-64. PubMed ID: 20658653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
    Kupelian PA; Elshaikh M; Reddy CA; Zippe C; Klein EA
    J Clin Oncol; 2002 Aug; 20(16):3376-85. PubMed ID: 12177097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
    J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of hospital volume on cancer control after radical prostatectomy.
    Ellison LM; Trock BJ; Poe NR; Partin AW
    J Urol; 2005 Jun; 173(6):2094-8. PubMed ID: 15879850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison.
    Eldefrawy A; Katkoori D; Abramowitz M; Soloway MS; Manoharan M
    Urol Oncol; 2013 Jul; 31(5):576-80. PubMed ID: 21616691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical prostatectomy vs radiotherapy vs observation among older patients with clinically localized prostate cancer: a comparative effectiveness evaluation.
    Sun M; Sammon JD; Becker A; Roghmann F; Tian Z; Kim SP; Larouche A; Abdollah F; Hu JC; Karakiewicz PI; Trinh QD
    BJU Int; 2014 Feb; 113(2):200-8. PubMed ID: 23937636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.
    Akakura K; Isaka S; Akimoto S; Ito H; Okada K; Hachiya T; Yoshida O; Arai Y; Usami M; Kotake T; Tobisu K; Ohashi Y; Sumiyoshi Y; Kakizoe T; Shimazaki J
    Urology; 1999 Aug; 54(2):313-8. PubMed ID: 10443731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radical prostatectomy improves survival in selected metastatic prostate cancer patients: A North American population-based study.
    Stolzenbach LF; Deuker M; CollĂ -Ruvolo C; Nocera L; Tian Z; Maurer T; Steuber T; Tilki D; Briganti A; Saad F; Chun FK; Graefen M; Karakiewicz PI
    Int J Urol; 2021 Aug; 28(8):834-839. PubMed ID: 34047401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of early-stage prostate cancer among rural and urban patients.
    Baldwin LM; Andrilla CH; Porter MP; Rosenblatt RA; Patel S; Doescher MP
    Cancer; 2013 Aug; 119(16):3067-75. PubMed ID: 23765584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer.
    Arcangeli G; Strigari L; Arcangeli S; Petrongari MG; Saracino B; Gomellini S; Papalia R; Simone G; De Carli P; Gallucci M
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):975-82. PubMed ID: 19395188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.